| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2567 | 2014 |
| High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma ET Kimura, MN Nikiforova, Z Zhu, JA Knauf, YE Nikiforov, JA Fagin Cancer research 63 (7), 1454-1457, 2003 | 1931 | 2003 |
| Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, ... Journal of clinical oncology 30 (2), 134-141, 2012 | 1635 | 2012 |
| BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas MN Nikiforova, ET Kimura, M Gandhi, PW Biddinger, JA Knauf, F Basolo, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5399-5404, 2003 | 1292 | 2003 |
| Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1091 | 2016 |
| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ... Jama 309 (14), 1493-1501, 2013 | 1049 | 2013 |
| Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify … RM Tuttle, H Tala, J Shah, R Leboeuf, R Ghossein, M Gonen, M Brokhin, ... Thyroid 20 (12), 1341-1349, 2010 | 1040 | 2010 |
| Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer AL Ho, RK Grewal, R Leboeuf, EJ Sherman, DG Pfister, D Deandreis, ... New England Journal of Medicine 368 (7), 623-632, 2013 | 880 | 2013 |
| Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules YE Nikiforov, DL Steward, TM Robinson-Smith, BR Haugen, JP Klopper, ... The Journal of Clinical Endocrinology & Metabolism 94 (6), 2092-2098, 2009 | 844 | 2009 |
| High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. JA Fagin, K Matsuo, A Karmakar, DL Chen, SH Tang, HP Koeffler The Journal of clinical investigation 91 (1), 179-184, 1993 | 831 | 1993 |
| Biologic and clinical perspectives on thyroid cancer JA Fagin, SA Wells Jr New England Journal of Medicine 375 (11), 1054-1067, 2016 | 830 | 2016 |
| Distinct Pattern of ret Oncogene Rearrangements in Morphological Variants of Radiation-induced and Sporadic Thyroid Papillary Carcinomas in Children YE Nikiforov, JM Rowland, KE Bove, H Monforte-Munoz, JA Fagin Cancer Research 57 (9), 1690-1694, 1997 | 823 | 1997 |
| A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies JS Forrester, M Fishbein, R Helfant, J Fagin Journal of the American College of Cardiology 17 (3), 758-769, 1991 | 798 | 1991 |
| Clonal origin of pituitary adenomas V HERMAN, J FAGIN, R GONSKY, K KOVACS, S MELMED The Journal of Clinical Endocrinology & Metabolism 71 (6), 1427-1433, 1990 | 692 | 1990 |
| Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera, A Heguy, M Ladanyi, ... Cancer research 69 (11), 4885-4893, 2009 | 648 | 2009 |
| Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification RE Schweppe, JP Klopper, C Korch, U Pugazhenthi, M Benezra, ... The Journal of Clinical Endocrinology & Metabolism 93 (11), 4331-4341, 2008 | 626 | 2008 |
| Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas P Lito, CA Pratilas, EW Joseph, M Tadi, E Halilovic, M Zubrowski, ... Cancer cell 22 (5), 668-682, 2012 | 601 | 2012 |
| Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ... Journal of clinical oncology 33 (1), 42-50, 2015 | 598 | 2015 |
| Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer R Ciampi, JA Knauf, R Kerler, M Gandhi, Z Zhu, MN Nikiforova, HM Rabes, ... The Journal of clinical investigation 115 (1), 94-101, 2005 | 572 | 2005 |
| Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells MN Nikiforova, JR Stringer, R Blough, M Medvedovic, JA Fagin, ... Science 290 (5489), 138-141, 2000 | 562 | 2000 |
